The latest issue of Financial Standard now available as an e-newspaper
|Showing 1 - 2 of 2 results for "Elastagen"|
|... specialist Brandon Capital were behind three of the four medical devices to receive grants. The Brandon and ATP backed Elastagen received a $4 million grant to fund the commercial manufacture of a tissue repair technology called Tropoelastin that helps ...|
|... completed three investments in new therapy and neurological disease firm, Nuon Therapeutics; research and development firm, Elastagen and clinical developer, Peplin. Brigitte Smith, GBS managing director, said to attain more than $100 million in commitments ...|
Pallas Capital has introduced a new short term fund that will invest in real estate assets in Sydney, Melbourne and Brisbane.
A new study on the prevalence of insider cybersecurity threats, commissioned by Proofpoint to the Ponemon Institute, has revealed just how much insider attacks are costing financial services firms.
Mayfair 101 has confirmed it will appeal the 2021 Federal Court decision that found its advertising misled and deceived investors.
Sustainable investors tend to favour environmental-themed strategies over social ones as the former is more tangible and easier to measure.
|Brought to you by|
|Keep up to date, don't be the last to know! Get the Financial Standard Daily Newsletter.|